Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NY/Syracuse
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Syracuse, NY

Studies commonly pay $75 to $4,500 per completed study

249 clinical trials are currently recruiting participants within 30 miles of Syracuse. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

249studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Syracuse right now

Top 25 of 249 recruiting studies, sorted by proximity — each links to its official registry page

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Non-Muscle Invasive Bladder Neoplasms Phase 3 Interventional 641 participants sought
Associated Medical Professionals of Ny — Syracuse, New York (0.5 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06319820)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Syracuse, New York (0.5 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05099003)

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Carcinoma, Non-small-Cell Lung Phase 2 Interventional 520 participants sought
Hematology-Oncology Associates of CNY — East Syracuse, New York (3.7 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT05498428)

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer Phase 3 Interventional 600 participants sought
SUNY Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06793215)

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Aortoiliac Occlusive Disease N/A Observational 158 participants sought
Research Foundation at SUNY Syracuse — Syracuse, New York (0.5 mi) · Sponsor: W.L.Gore & Associates
See eligibility & contact on ClinicalTrials.gov (NCT06872905)

Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief

Neck Pain Musculoskeletal, Neck Pain Treatment N/A Interventional 160 participants sought
PROActivePT — Syracuse, New York (0.5 mi) · Sponsor: Baylor University
See eligibility & contact on ClinicalTrials.gov (NCT06906107)

Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

Neurogenic Detrusor Overactivity Phase 2, Phase 3 Interventional 71 participants sought
SUNY Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: Urovant Sciences GmbH
See eligibility & contact on ClinicalTrials.gov (NCT05491525)

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm Phase 2 Interventional 70 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06126276)

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Atopic Dermatitis N/A Observational 1,000 participants sought
Galderma Investigational Site # 7052 — East Syracuse, New York (3.7 mi) · Sponsor: Galderma R&D
See eligibility & contact on ClinicalTrials.gov (NCT06988605)

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Malignancy N/A Observational 240 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04242095)

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Metastatic Hormone-sensitive Prostate Cancer Phase 2 Interventional 150 participants sought
Associated Med Professionals of NY — Syracuse, New York (0.5 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06991556)

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Lupus Nephritis, Primary Membranous Nephropathy Phase 1, Phase 2 Interventional 120 participants sought
Nkarta Investigational Site — Syracuse, New York (0.5 mi) · Sponsor: Nkarta, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06557265)

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

HER2-positive Breast Cancer, Breast Cancer Phase 2 Interventional 125 participants sought
Hematology Oncology Associates of Central New York — Camillus, New York (8.1 mi) · Sponsor: Jazz Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07102381)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

Hypertension N/A Interventional 261 participants sought
St. Joseph — Liverpool, New York (5.9 mi) · Sponsor: SoniVie Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06559891)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Geographic Atrophy, Macular Degeneration Phase 2 Interventional 274 participants sought
Retina-Vitreous Surgeons of Central New York — Liverpool, New York (5.9 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06635148)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)
Actively enrolling

Studies you may be able to join near Syracuse

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Syracuse

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Developmental Psychology Clinical Research Center

Syracuse, NY 13210

Ichor Research

★ 5.0
1101 Erie Blvd E #201, Syracuse, NY 13210
(315) 904-5004
"Christy and team were great. No wait, when I got there. Everything explained clear and to the point. And at least gor why I was there ...great to get…"
— Michael Gilman, 5★

Velocity Clinical Research

★ 4.2
5000 Brittonfield Pkwy Ste B105, East Syracuse, NY 13057
(315) 760-5905
"Excellent staff, communication and access to information. Would gladly participate again in other trials!"
— Suzi Harriff, 5★

Crouse Hospital

★ 3.1
736 Irving Ave, Syracuse, NY 13210
(315) 470-7111

Upstate Biotech Accelerator

★ 4.7
841 E Fayette St, Syracuse, NY 13210
(315) 464-9288
"Well developed, entrepreneurial space."
— Ty A. Austin, 5★

Upstate Health Care Center

★ 4.1
90 Presidential Plaza, Syracuse, NY 13202
(315) 464-5240
"Dr. Carhart and his staff are fabulous, very kind. Dr. Carhart always has a great smile, is kund and never rushes uou. He answers all your questions…"
— Linda Tomczyk, 5★

Central NY Clinical Research

4500 Pewter Ln #2, Manlius, NY 13104
(315) 682-3263

Syracuse VA Medical Center

★ 3.9 (254 reviews)
800 Irving Ave, Syracuse, NY 13210
(315) 425-4400
"This place hasn’t changed in years. It’s just as terrible now as it was when my grandfather was neglected there years ago. Today, patients sit in the…"
— Tricia Loomis, 1★

Associated Medical Professionals of NY, Syracuse

★ 4.8
1226 E Water St Ste D, Syracuse, NY 13210
(315) 478-4185
"Sara knows her stuff! She’s very nice and great to be one of her patients."
— Vicki Vescio, 5★

Clinical trials in Syracuse: what's recruiting

The Syracuse area currently has 249 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Syracuse, the most active research areas are:

  • Cancer & Oncology12 studies
  • Immune & Skin3 studies
  • Heart & Vascular1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Syracuse, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Syracuse

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Syracuse participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Syracuse pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Syracuse safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Syracuse?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Syracuse typically complete one or two studies per year.

Paid clinical trials near Syracuse

Other metros within reach

Binghamton, NY21 Rochester, NY471 Scranton, PA99 Albany, NY197 Allentown, PA234 Poughkeepsie, NY77 Buffalo, NY516 Reading, PA280

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Syracuse Bladder Issues Due To Spinal Cord Injury in Syracuse All conditions

More of NY

Staten Island4,271 Brooklyn4,269 New York4,206 Manhattan4,198 Bronx4,178 Queens4,161 Yonkers4,153 Buffalo516 Rochester471 Albany197 Poughkeepsie77

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts